Hypertrophic Cardiomyopathy Podcasts

Presenters: Miguel Leal, MD, FACC, FHRS; Judy Hung, MD and Antonio Pelliccia, MD; Ava Van der Mee

Summary: It is estimated that 1 in every 500 adults living in the U.S. have HCM, but a large percentage of patients are undiagnosed. Listen to this podcast to gain insight into hypertrophic cardiomyopathy (HCM) screening and what it means to your patients.

Presenters: Ferhaan Ahmad, MD, PhD, FRCPC, FAHA, FACC; Sara Saberi, MD, MS; Anjali Tiku Owens, MD; Pastor Kent Sperry, MDiv

Summary: Making the correct of hypertrophic cardiomyopathy (HCM) is critical in being able to initiate early surveillance and therapy to improve patient outcomes. In this podcast focusing on pharmacologic treatment options, learn more about completed and ongoing myosin inhibitor clinical trials.

Presenters: Ferhaan Ahmad, MD, PhD; Martha Grogan, MD; Matthew R. G. Taylor, MD, PhD; Tom Cilek

Summary: Accurate diagnosis of Hypertrophic Cardiomyopathy (HCM) is critical. HCM is a chronic and progressive disease putting patients at risk of serious complications and co-morbidities.  Early and correct detection may help reduce some of the consequences of HCM and improve outcomes. In this podcast, learn more about how to distinguish phenocopies from HCM.

Presenters: Vlad Zaha, MD, PhD; William Zoghbi MD, MACC; Said Alsidawi, MD, FACC; Cristina Iaboni

Summary: Diagnosis of hypertrophic cardiomyopathy is typically done by echocardiogram to assess the thickness of the heart muscle and observe blood flow in and out of the heart. In this podcast, learn more about how echocardiography is used in the diagnosis, screening, and management of HCM.

Presenters: Miguel Leal, MD; Seema Mital, MD; Shelley Miyamoto, MD; Alison Conklin

Summary: Hypertrophic cardiomyopathy (HCM) is the most common form of inherited heart disease and can affect people of any age. In this episode, learn what causes hypertrophic cardiomyopathy in children and the clinical and genetic screening needed to diagnosis HCM.

Presenters: Theodore Abraham, MD; Sharlene Day, MD; Matthew Martinez, MD; Brian Metz, MD

Summary:  Although the cardiovascular and overall health benefits of regular activity are well-established, recommendations for recreational exercise and competitive sports participation for patients with HCM have been challenging. Listen to this podcast as Drs. Abraham, Day, and Martinez along with Brian Metz discuss exercising with HCM and the importance of shared decision making with the healthcare team.

Presenters: Vlad Zaha, MD, PhD; Jose Joglar, MD; Jessica Chowns, MS, CGC; Paul McDermott

Summary: Hypertrophic cardiomyopathy (HCM) is the most common form of genetic heart disease and can affect people of any age, yet it often goes undiagnosed. Genetic testing and counseling plays an important role in the diagnosis and management of HCM in patients in families. Learn more about genetic testing and counseling, and its impact on the patient’s family.

Presenters: Miguel Leal, MD; Ethan Rowin, MD; Iacopo Olivotto, MD; Ross Hadley

Summary: People with HCM are at increased risk for developing arrhythmias such as atrial fibrillation, suffering from stroke and even sudden cardiac arrest. People with HCM face a risk of death more than 3 times greater than the average person of the same age without HCM. Learn more about the complex relation between atrial fibrillation and hypertrophic cardiomyopathy.

Presenters: Ahmet Kilic, MD; Anjali Tiku Owens, MD, Ferhaan Ahmad, MD, PhD, FRCPC, FAHA, FACC, Ovuke' Emonina McCoy

Summary: Surgical and interventional options such as surgical myectomy or alcohol septal ablation may help those with obstructive HCM to reduce or remove the obstruction. A similar option is unavailable to those with non-obstructive HCM. Heart transplants are considered as a last resort for HCM patients who progress to end stages of the disease. Learn more about advanced surgical approaches and emerging medical therapies for HCM.

Presenters: Dr. Robert Fraser, Dr. Michelle Kittleson, Dr. Michael Burke, Kathryn Redmond

Summary: There are different types of hypertrophic cardiomyopathy. Most people with HCM have a form of the disease in which the wall that separates the two bottom chambers of the heart becomes enlarged and restricts blood flow out of the heart (obstructive hypertrophic cardiomyopathy). Sometimes HCM occurs without significant blocking of blood flow (nonobstructive hypertrophic cardiomyopathy). However, the heart's main pumping chamber is still thickened and may become increasingly stiff, reducing the amount of blood taken in and then pumped out to the body with each heartbeat. Learn more about the differences between obstructive and nonobstructive hypertrophic cardiomyopathy so you are better able to discuss its impact with your patients.

Presenters: Dr. Miguel Leal, Dr. Carey Kimmelstiel, Dr. Hartzell Schaff, Adam Elliott

Summary: Surgical and interventional options such as surgical myectomy or alcohol septal ablation may help those with obstructive HCM to reduce or remove the obstruction. Patient Adam Elliot talks with Drs. Leal, Kimmelstiel, and Schaff as they clarify the state of the art available therapies, techniques, and explain which patients are more likely to benefit from them throughout their journey.

Presenters: Vlad G. Zaha, MD, Martin S. Maron, MD, Albree Tower-Rader, MD, Shawn Lewis

Summary: People with HCM can experience fatigue, fainting, shortness of breath, chest pain or heart palpitations. The severity of symptoms can vary from person to person. HCM can be a progressive disease that can get worse over time and result in symptoms that leave patients feeling worse and able to do fewer of the activities they love. This reduced functionality can be one of the most challenging aspects of the disease. Drs. Zaha, Maron, and Tower-Rader join patient Shawn Lewis in exploring the spectrum of symptoms and the complexities of accurate diagnosis in HCM.

Presenters: Dr. Zaha, Dr. Cresci, Dr. Abraham and patient representative Gwen Mayes

Summary: How to Bridge Patients’ Reflections and a Specialist Recommendations podcast is a discussion on differential diagnosis of Hypertrophic Cardiomyopathy (HCM) compared to other diseases.

Presenters: Dr. Leal, Dr. Gopinathannair, Dr. Owens, and Kristen Criss (Patient Representative)

Summary: Defibrillator (ICD) Therapy: Selecting the Appropriate Patient podcast presented by Dr. Miguel Leal, Dr. Rakesh Gopinathannair, and Dr. Anjali Owens along with Kristen Criss focuses on the appropriate selection of patients for ICD therapy, including assessment of risk factors and a comprehensive discussion of risks and benefits of ICD therapy in this specific patient population.

Presenters: Dr. Fraser, Dr. Leal, Adam Elliott

Summary: The Office Visit: Tracking Symptoms, Function, Quality of Life podcast presented by Dr. Robert Fraser, Dr. Miguel Leal, Adam Elliott discusses hypertrophic cardiomyopathy in many of its complex aspects that essentially are part of the day-to-day care of any cardiologist and patient who deal with this condition.

Presenters: Dr. Vlad Zaha and Dr. Ferhaan Ahmad

Summary: Join Dr. Vlad Zaha and Dr. Ferhaan Ahmad as they discusses how healthcare providers make a diagnosis of hypertrophic cardiomyopathy and how they distinguish it from other disorders that can look like hypertrophic cardiomyopathy.

Presenters: Dr. Robert Fraser, Dr. Miguel Leal, and Dr. Ferhaan Ahmad

Summary: Hypertrophic Cardiomyopathy: A 7 Point Introduction is an introductory discussion on hypertrophic cardiomyopathy. Our presenters, Dr. Robert Fraser, Dr. Miguel Leal, and Dr. Ferhaan Ahmad, discuss the epidemiology of hypertrophic cardiomyopathy, its history, its genetics, how to diagnose it, and the symptoms patients experience with hypertrophic cardiomyopathy.